Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Rectal Neoplasms 1Ovarian Neoplasms 1

Interventions

pembrolizumab 20Cisplatin 20Cetuximab 13Carboplatin 11Magnetic Resonance Spectroscopy 9Specimen Handling 8Paclitaxel 8Docetaxel 8Radiotherapy, Intensity-Modulated 7Platinum 7Nivolumab 71,2-diaminocyclohexaneplatinum II citrate 7dostarlimab 4Radiotherapy 4Immunoglobulin G 4Fluorouracil 4Disulfides 4Biopsy 4(225)Ac-DOTA-c(RGDyK) 4atezolizumab 3Taxes 3Radiation 3Bevacizumab 3cemiplimab 2amivantamab 2abemaciclib 2Pemetrexed 2Ipilimumab 2Fulvestrant 2130-nm albumin-bound paclitaxel 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Squamous Cell Carcinoma of Head and Neck × Endoscopy × 30 days × Clear all
NCT07392580 2026-06-01

Intralesional Chemotherapy (IC): Cisplatin + Epinephrine

University of Miami

Phase 2 Recruiting
20 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck

Data powered by HemOnc (CC BY 4.0) Colophon âš¡